| Latest Genesis Bioventures News Headlines |
| Date | Time | Source | |
| 10/03/2005 | 5:45PM | PRNUS | Genesis Bioventures Announces Notice from American Stock Exchange
NEW YORK, Oct. 3 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc. (AMEX:GBI) (GBI) today reported that further to the Form 8-K submitted on July 27, 2005 with respect to the Notice from the American Stock Exchange (the "Amex" or "Exchange") indicating that GBI was not in compliance with certain subsections of Sections... More...>> |
| 07/27/2005 | 6:03PM | PRNUS | Genesis Bioventures Announces Notice from American Stock Exchange
Genesis Bioventures Announces Notice from American Stock Exchange
NEW YORK, July 27 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
(AMEX:GBI) (GBI) today reported that it has received written notice (the
"Notice") from the American Stock Exchange (the "Amex" or "Exchange") that the
Company does not meet certain... More...>> |
| 06/01/2005 | 9:30AM | PRNUS | Genesis Bioventures signs agreement for control of Mad Cow diagnostic company
Genesis Bioventures signs agreement for control of Mad Cow
diagnostic company
NEW YORK, June 1 /PRNewswire-FirstCall/ -- Further to a Letter of Intent
previously reported, Genesis Bioventures, Inc. (AMEX:GBI) (the "Company" or
"GBI") today announced that it has entered into a binding agreement (the
"Agreement") with... More...>> |
| 05/18/2005 | 2:52PM | PRNUS | Genesis Bioventures Receives Extension from American Stock Exchange
Genesis Bioventures Receives Extension from American Stock
Exchange
NEW YORK, May 18 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
(AMEX:GBI) (GBI) today reported that it has received a letter (the "Letter")
from the American Stock Exchange (the "Amex" or "Exchange") in response to the
Company's plan of compliance... More...>> |
| 04/26/2005 | 1:02PM | PRNUS | Genesis Bioventures Announces Notice from American Stock Exchange
Genesis Bioventures Announces Notice from American Stock Exchange
NEW YORK, NY, April 26 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
(AMEX:GBI) (GBI) today reported that it has received written notice (the
"Notice") from the American Stock Exchange (the "Amex" or "Exchange") that the
Company is not in compliance... More...>> |
| 04/18/2005 | 2:14PM | PRNUS | Genesis Bioventures Announces 2004 Annual Report Delay and Releases Unaudited Preliminary 2004 Results
Genesis Bioventures Announces 2004 Annual Report Delay and
Releases Unaudited Preliminary 2004 Results
NEW YORK, NY, April 18 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
(AMEX:GBI) (GBI) today reported that its Annual Report on Form 10-KSB for the
year ended December 31, 2004 was not filed by the deadline of... More...>> |
| 01/18/2005 | 9:30AM | PRNUS | Genesis Bioventures reports corporate update
Genesis Bioventures reports corporate update
NEW YORK, NY, Jan. 18 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
(AMEX:GBI) ("GBI") today reported that the previously announced merger with
Corgenix Medical Corporation (OTCBB:CONX) ("Corgenix") has been terminated.
Corgenix notified the Company that its board of... More...>> |
| 01/14/2005 | 11:35AM | PRNUS | Skinvisible Announces New Board of Directors Member
Skinvisible Announces New Board of Directors Member
Greg McCartney, President of AMEX Listed Genesis Bioventures, Brings Biotech &
Healthcare Industry Experience to Board of Directors
LAS VEGAS, Jan. 14 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC:SKVI)
(BULLETIN BOARD: SKVI) (Website: http://www.skinvisible.com/... More...>> |
| 11/15/2004 | 7:00AM | PRNUS | Corgenix Announces First Quarter Results and Merger Update
Corgenix Announces First Quarter Results and Merger Update
DENVER, Nov. 15 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation
(OTC:CONX) (BULLETIN BOARD: CONX) today announced financial results for the
quarter ended September 30, 2004.
Sales for the first quarter of fiscal 2004 increased 8.4% to $1,303,071
compared... More...>> |
| 11/08/2004 | 7:00AM | PRNUS | Collaboration for Aspirin Resistance Testing Announced by Corgenix Medical Corporation, Creative Clinical Concepts, Inc. and McM
Collaboration for Aspirin Resistance Testing Announced by
Corgenix Medical Corporation, Creative Clinical Concepts, Inc. and McMaster
University
Technology Used to Determine a Patient's Response to Aspirin Therapy Taken to
Prevent Heart Attacks
DENVER, and HAMILTON, Canada, Nov. 8 /PRNewswire-FirstCall/ -- Corgenix
Medical... More...>> |
| 10/14/2004 | 7:00AM | PRNUS | Corgenix Announces Record Revenues in Fiscal 2004
Corgenix Announces Record Revenues in Fiscal 2004
DENVER, Oct. 14 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation
(OTC:CONX) (BULLETIN BOARD: CONX) today announced financial results for the
fiscal year ended June 30, 2004.
Sales for the fiscal year ended June 30, 2004 increased 4.9% to $5,270,553, a
new record... More...>> |
| 08/19/2004 | 1:32PM | PRNUS | Corgenix and Autoimmune Technologies Complete Development of Diagnostic Product for Fibromyalgia
Corgenix and Autoimmune Technologies Complete Development of
Diagnostic Product for Fibromyalgia
Test Kit for Anti-Polymer Antibodies (APA) to Be Launched This Year Through
Corgenix Distribution Organization
WESTMINSTER, Colo., Aug. 19 /PRNewswire-FirstCall/ -- Corgenix Medical
Corporation (OTC:CONX) (BULLETIN BOARD:... More...>> |
| 06/03/2004 | 5:02PM | PRNUS | Efoora Signs Major Strategic Agreement With Partner in Mad Cow Diagnostics Company
Efoora Signs Major Strategic Agreement With Partner in Mad Cow
Diagnostics Company
BUFFALO GROVE, Ill., June 3 /PRNewswire/ -- Efoora, Inc. (Efoora), today
announced that it has entered into a Cooperation Agreement (the "Agreement")
with Genesis Bioventures, Inc. (AMEX:GBI), Corgenix Medical Corporation
(OTC:CONX) (BULLETIN... More...>> |
| 06/02/2004 | 2:14PM | PRNUS | Genesis Bioventures enters into strategic agreement
Genesis Bioventures enters into strategic agreement
NEW YORK, NY, June 2 /PRNewswire-FirstCall/ -- As previously announced,
Genesis Bioventures, Inc. (AMEX:GBI), and Corgenix Medical Corporation
(Corgenix) (OTCBB:CONX) have entered into an Agreement and Plan of Merger that
the parties are seeking to complete on or about... More...>> |
| 06/02/2004 | 2:11PM | PRNUS | Genesis Bioventures files secondary registration statement
Genesis Bioventures files secondary registration statement
NEW YORK, June 2 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc.
(AMEX:GBI), today announced that the Company has filed a secondary registration
statement relating to the re-sale of certain shares of the Company's common
stock. The registration statement... More...>> |
| 03/25/2004 | 4:33PM | PRNUS | Genesis Bioventures clarifies merger stock ratio
Genesis Bioventures clarifies merger stock ratio
NEW YORK, March 25 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc. today
announced that it has received inquiries from shareholders with respect to the
conversion of common stock related to the proposed merger with Corgenix Medical
Corporation (OTCBB:CONX) (Corgenix).
Under... More...>> |
| 03/25/2004 | 8:45AM | PRNUS | Genesis Bioventures Completes US$2 Million Bridge Financing and Definitive Merger Agreement with Corgenix Medical Corporation
Genesis Bioventures Completes US$2 Million Bridge Financing and Definitive
Merger Agreement with Corgenix Medical Corporation
NEW YORK, March 25 /PRNewswire/ -- Genesis Bioventures, Inc. (AMEX:GBI)
today announced that it has
completed a bridge financing related to the previously announced proposed
merger with Corgenix... More...>> |
| 03/25/2004 | 8:45AM | PRNUS | Genesis Bioventures completes $2 million bridge financing and definitive merger agreement with Corgenix Medical Corporation
Genesis Bioventures completes $2 million bridge financing and definitive merger
agreement with Corgenix Medical Corporation
NEW YORK, March 25 /PRNewswire-FirstCall/ -- Genesis Bioventures, Inc. today
announced that it has completed a bridge financing related to the previously
announced proposed merger with Corgenix... More...>> |
| 03/16/2004 | 11:10AM | PRNUS | Corgenix Medical Corporation and Genesis Bioventures Announce Signing of Merger Agreement and Completion of $2 Million Initial F
Corgenix Medical Corporation and Genesis Bioventures Announce Signing of Merger
Agreement and Completion of $2 Million Initial Financing Round
DENVER, March 16 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation
(BULLETIN BOARD: CONX) and Genesis Bioventures, Inc. today announced the
signing of a definitive merger... More...>> |
| 03/03/2004 | 1:32PM | PRNUS | Genesis Bioventures erhält USDA-Zulassung
Genesis Bioventures erhält USDA-Zulassung
NEW YORK, March 3 /PRNewswire/ -- Prion Developmental Laboratories (PDL),
Portfolio-Unternehmen von Genesis
Bioventures (AMEX: GBI), hat für seinen CWD-Streifentest die Zulassung des
US-Landwirtschaftsministeriums (USDA) erhalten. Der Test dient zur Erkennung
des Chronic... More...>> |